Treatment of tumor cells with histone deacetylase inhibitors results in altered recruitment of methyl-CpG binding proteins to a methylated CpG island

Biological Chemistry

Volumn 384, Issue 5, 2003, Pages 787-790

  Koizume, Shiro ^a   Tachibana, Ken ^a,b   Shiraishi, Masahiko ^a  

^a NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

^b TOKYO UNIVERSITY OF SCIENCE   (Japan)

Author keywords

Chromatin immunoprecipitation; Histone acetylation; Histone deacetylase inhibitor; Methyl CpG binding protein

Indexed keywords

BUTYRIC ACID; HISTONE; HISTONE DEACETYLASE INHIBITOR; METHYL CPG BINDING PROTEIN; TRICHOSTATIN A;

ACETYLATION; ARTICLE; CHROMATIN STRUCTURE; CONTROLLED STUDY; CPG ISLAND; DEACETYLATION; GENE SILENCING; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN METHYLATION; TUMOR CELL;

ACETYLATION; CADHERINS; CELL LINE, TUMOR; CHROMATIN; CPG ISLANDS; DNA METHYLATION; DNA-BINDING PROTEINS; ENZYME INHIBITORS; FEMALE; GENETIC TECHNIQUES; HISTONE DEACETYLASES; HISTONES; HUMANS; PRECIPITIN TESTS;

EID: 0037870734     PISSN: 14316730     EISSN: None     Source Type: Journal    
DOI: 10.1515/BC.2003.087     Document Type: Article

References (19)

1. Amir, R. E., Van den Veyver, I. B., Wan, M., Tran, C. Q., Franke, U., and Zoghbi, H. Y. (1999). Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG binding protein 2. Nature Genet. 23, 185-188.
2. Bird, A. P., and Wolffe, A. R (1999). Methylation-induced repression-belts, braces, and chromatin. Cell 99, 451-454.
3. Chen, R. Z., Akbarian, S., Tudor, M., and Jaenisch, R. (2001). Deficiency of methyl-CpG binding protein-2 in CNS neurons results in a Rett-like phenotype in mice. Nature Genet. 27,327-331.
4. Chen, T M., and Townes, T M. (2000). Molecular mechanism for silencing virally transduced genes involves histone deacetylation and chromatin condensation. Proc. Natl. Acad. Sci. USA 97, 377-382.
5. Di Croce, L, Raker, V. A., Corsaro, M., Fazi, F., Fanelli, M., Faretta, M., Fuks, F., Lo Coco, F, Kouzarides, T, Nervi, C., Minucci, S., and Pelicci, P. G. (2002). Methyltransferase recruitment and DNA hypermethylation of target promoters by an oncogenic transcription factor. Science 295, 1079-1082.
6. El-Osta, A., Kantharidis, P, Zalcberg, J. R., and Wolffe, A. P. (2002). Precipitous release of methyl-CpG binding protein 2 and histone deacetylase 1 from the methylated human multidrug resistance gene (MDR1) on activation. Mol. Cell. Biol. 22, 1844-1857.
7. Gregory, R. I., Randall, T E., Johnson, C. A., Khosla, S., Hatada, I., O'Neill, L. R, Turner, B. M., and Feil, R. (2001). DNA methylation is linked to deacetylation of histone H3, but not H4, on the imprinted genes Snrpn and U2af1-rs1. Mol. Cell Biol. 21, 5426-5436.
8. Gregory, R. I., O'Neill, L. P., Randall, T. E., Fournier, C., Khosia, S., Turner, B. M., and Fail, R. (2002). Inhibition of histone deacetylases alters allelic chromatin conformation at the imprinted U2af1-rs1 locus in mouse embryonic stem cells. J. Biol. Chem. 277, 11728-11734.
9. Guy, J., Hendrich, B., Holmes, M., Martin, J. E., and Bird, A. (2001). A mouse Mecp2-null mutation causes neurological symptoms that mimic Rett syndrome. Nature Genet. 27, 322-326.
10. Hendrich, B., and Bird, A. (1998). Identification and characterization of a family of mammalian methyl-CpG binding proteins. Mol. Cell Biol. 18, 6538-6547.
11. Knoepfler, P. S., and Eisenman, R. N. (1999). Sin meets NuRD and other tails of repression. Cell 99, 447-450.
12. Koizume, S., Tachibana, K., Sekiya, T., Hirohashi, S., and Shiraishi, M. (2002). Heterogeneity in the modification and involvement of chromatin components of the CpG island of the silenced human CDH1 gene in cancer cells. Nucleic Acids Res. 30, 4770-4780.
13. Lorincz, M. C., Schubeler, D., and Groudine, M. (2001). Methylation-mediated proviral silencing is associated with MeCP2 recruitment and localized histone H3 deacetylation. Mol. Cell Biol. 21, 7913-7922.
14. Magdinier, F., and Wolffe, A. P. (2001). Selective association of the methyl-CpG binding protein MBD2 with the silent p14/p16 locus in human neoplasia. Proc. Natl. Acad. Sci. USA 98, 4990-4995.
15. Nan, X., Campoy, F. J., and Bird, A. (1997). MeCP2 is a transcriptional repressor with abundant binding sites in genomic chromatin. Cell 88, 471-481.
16. Ng, H.-H., Jeppesen, R, and Bird, A. (2000). Active repression of methylated genes by the chromosomal protein MBD1. Mol. Cell Biol. 20, 1394-1406.
17. Nguyen, C. T., Gonzales, F. A., and Jones. P. A. (2001). Altered chromatin structure associated with methylation-induced gene silencing in cancer cells: correlation of accessibility, methylation, MeCP2 binding and acetylation. Nucleic Acids Res. 29, 4598-4606.
18. Ohki, I., Shimotake, N., Fujita, N., Jee, J., Ikegami, T, Nakao, M., and Shirakawa, M. (2001). Solution structure of the methyl-CpG binding domain of human MBD1 in complex with methylated DNA. Cell 105, 487-497.
19. Yu, F., Thiesen, J., and Strätling, W. H. (2000). Histone deacetylase-independent transcriptional repression by methyl-CpG-binding protein 2. Nucleic Acids Res. 28, 2201-2206.